Management of Myocardial Injury After Noncardiac Surgery Trial (MANAGE)
A Large, International, Randomized, Placebo-controlled Trial to Assess the Impact of Dabigatran (a Direct Thrombin Inhibitor) and Omeprazole (a Proton-pump Inhibitor) in Patients Suffering Myocardial Injury After Noncardiac Surgery
Sponsor: Population Health Research Institute
A PHASE3 clinical study on Myocardial Injury After Noncardiac Surgery (MINS), this trial is completed. The trial is conducted by Population Health Research Institute and has accumulated 9 data snapshots since 2013. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
▶ Show 4 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Sep 2017 — Apr 2018 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Feb 2017 — Sep 2017 [monthly]
Recruiting PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE3
First recorded
Jan 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Population Health Research Institute
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Bangalore, India , Barcelona, Spain , Belfast, United Kingdom , Belo Horizonte, Brazil , Bengaluru, India , Bloemfontein, South Africa , Bochnia, Poland , Bogotá, Colombia , Bonn, Germany , Brzesko, Poland and 59 more locations